Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026858 · ClinicalTrials.gov registry record · Phase 2

Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts

A Phase 2 study, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 2
Development phase
100
Enrollment target

NCT00026858: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).

NCT00026858 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 100 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00026858, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target

Study Summary

Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation. Techniques for administering that treatment, including patient positioning, lung and soft tissue compensation, dose rate, total dose and fractionation differ between institutions. These differences are optimized at each institution to limit toxicity and maximize therapeutic outcome. Technically complex procedures such as total body radiation are subject to equipment failures. Such failures mid-treatment could be catastrophic to the patient, since therapy must be timely and compatible therapy may not be available elsewhere in the community. The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly, safe, and compatible therapies in the event of equipment failure; or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI; or any emergent situation.

Interventions

  • BEHAVIORAL collaboration

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 1994-10
Est. Completion 2002-11
Phase Phase 2
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00026858 record still lists

NCT00026858 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower).

The record links to 0 conditions, and to 1 intervention - of which collaboration is the first listed.

NCT00026858 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00026858 about?

NCT00026858 is a clinical study titled "Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts". Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation. Techniques for administering that treatment, including patient positioning, lung and soft tissue compensation, dose rate, total dose and fractionation differ between institutions. These differen...

What is the current status of trial NCT00026858?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 1994-10. Estimated completion is 2002-11.

What interventions are being tested in trial NCT00026858?

The interventions under investigation include: collaboration (BEHAVIORAL).

Who is sponsoring clinical trial NCT00026858?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00026858's enrollment target sits among peer trials

100 672nd of 2000 higher than 1,263 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00026858, the US trial registry maintained by the National Library of Medicine. NCT00026858 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.